{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:01Z","timestamp":1707524641716},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.7759\/cureus.28697","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:27:55Z","timestamp":1662136075000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Inflammatory Bowel Disease on Mortality and Other Outcomes of Hospitalized Patients With Diabetic Ketoacidosis: An Observational Study of the United States National Inpatient Sample"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Aldiabat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Aljabiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassine","family":"Kilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubarak H","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad H","family":"Al-Khateeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Horoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farukhuddin","family":"Farukhuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratib","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adham E","family":"Obeidat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham C","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009, 361:2066-78. 10.1056\/NEJMra0804647","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein CN","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001, 96:1116-22. 10.1111\/j.1572-0241.2001.03756.x","journal-title":"Am J Gastroenterol"},{"key":"ref4","article-title":"Extracolonic diagnoses in ulcerative colitis: an epidemiological study","volume":"85","author":"Mons\u00e9n U","year":"1990","unstructured":"Mons\u00e9n U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990, 85:711-6.","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000282","article-title":"Microbial contributions to chronic inflammation and metabolic disease","volume":"19","author":"Shanahan F","year":"2016","unstructured":"Shanahan F, Sheehan D. Microbial contributions to chronic inflammation and metabolic disease. Curr Opin Clin Nutr Metab Care. 2016, 19:257-62. 10.1097\/MCO.0000000000000282","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.145","article-title":"The gut microbiota-a clinical perspective on lessons learned","volume":"9","author":"Shanahan F","year":"2012","unstructured":"Shanahan F. The gut microbiota-a clinical perspective on lessons learned. Nat Rev Gastroenterol Hepatol. 2012, 9:609-14. 10.1038\/nrgastro.2012.145","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer EB","year":"2014","unstructured":"Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. 2014, 43:75-102. 10.1016\/j.ecl.2013.10.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling ML","year":"2017","unstructured":"Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017, 23:6137-46. 10.3748\/wjg.v23.i33.6137","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030343","article-title":"Increased risk of diabetes in inflammatory bowel disease patients: a nationwide population-based study in Korea","volume":"8","author":"Kang EA","year":"2019","unstructured":"Kang EA, Han K, Chun J, Soh H, Park S, Im JP, Kim JS. Increased risk of diabetes in inflammatory bowel disease patients: a nationwide population-based study in Korea. J Clin Med. 2019, 8:343. 10.3390\/jcm8030343","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002","volume":"14","author":"Cohen R","year":"2008","unstructured":"Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis. 2008, 14:738-43. 10.1002\/ibd.20406","journal-title":"Inflamm Bowel Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1852","article-title":"Diabetic ketoacidosis in type 2 diabetes mellitus","volume":"31","author":"Puttanna A","year":"2014","unstructured":"Puttanna A, Padinjakara R. Diabetic ketoacidosis in type 2 diabetes mellitus. Practic Diabet. 2014, 31:155-8. 10.1002\/pdi.1852","journal-title":"Practic Diabet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03246.x","article-title":"Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis","volume":"28","author":"Savage MW","year":"2011","unstructured":"Savage MW, Dhatariya KK, Kilvert A, et al.. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011, 28:508-15. 10.1111\/j.1464-5491.2011.03246.x","journal-title":"Diabet Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi AE","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009, 32:1335-43. 10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb CA","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al.. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019, 68:s1-s106. 10.1136\/gutjnl-2019-318484","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref16","article-title":"","author":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP)","year":"2021","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD; 2021."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1179546820955179","article-title":"An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database","volume":"14","author":"Mubasher M","year":"2020","unstructured":"Mubasher M, Syed T, Hanafi A, et al.. An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database. Clin Med Insights Cardiol. 2020, 14:1179546820955179. 10.1177\/1179546820955179","journal-title":"Clin Med Insights Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06439-4","article-title":"Comorbid diabetes in inflammatory bowel disease predicts adverse disease-related outcomes and infectious complications","volume":"66","author":"Kumar A","year":"2021","unstructured":"Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. Comorbid diabetes in inflammatory bowel disease predicts adverse disease-related outcomes and infectious complications. Dig Dis Sci. 2021, 66:2005-13. 10.1007\/s10620-020-06439-4","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang YZ","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014, 20:91-9. 10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0009922808323907","article-title":"Diabetic ketoacidosis: a current appraisal of pathophysiology and management","volume":"48","author":"Koul PB","year":"2009","unstructured":"Koul PB. Diabetic ketoacidosis: a current appraisal of pathophysiology and management. Clin Pediatr (Phila). 2009, 48:135-44. 10.1177\/0009922808323907","journal-title":"Clin Pediatr (Phila)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4158\/EP08331.RAR","article-title":"Glucocorticoid-induced hyperglycemia","volume":"15","author":"Clore JN","year":"2009","unstructured":"Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009, 15:469-74. 10.4158\/EP08331.RAR","journal-title":"Endocr Pract"},{"key":"ref22","article-title":"Steroid-induced diabetic ketoacidosis in a patient with type 2 diabetes mellitus","volume":"4","author":"Tiwari A","year":"2018","unstructured":"Tiwari A, Al-Robeh H, Sharma H, et al.. Steroid-induced diabetic ketoacidosis in a patient with type 2 diabetes mellitus. AACE Clinic Case Rep. 2018, 4:131-3.","journal-title":"AACE Clinic Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s001470050011","article-title":"Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series","volume":"13","author":"Yoshida EM","year":"2000","unstructured":"Yoshida EM, Buczkowski AK, Sirrs SM, et al.. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. Transpl Int. 2000, 13:69-72. 10.1007\/s001470050011","journal-title":"Transpl Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e31823c9a11","article-title":"Nutritional status and complications in children with diabetic ketoacidosis","volume":"13","author":"Moulik NR","year":"2012","unstructured":"Moulik NR, Jayashree M, Singhi S, Bhalla AK, Attri S. Nutritional status and complications in children with diabetic ketoacidosis. Pediatr Crit Care Med. 2012, 13:e227-33. 10.1097\/PCC.0b013e31823c9a11","journal-title":"Pediatr Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0721-y","article-title":"Stress hyperglycemia during surgery and anesthesia: pathogenesis and clinical implications","volume":"16","author":"Palermo NE","year":"2016","unstructured":"Palermo NE, Gianchandani RY, McDonnell ME, Alexanian SM. Stress hyperglycemia during surgery and anesthesia: pathogenesis and clinical implications. Curr Diab Rep. 2016, 16:33. 10.1007\/s11892-016-0721-y","journal-title":"Curr Diab Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000195975.97673.f5","article-title":"Increased insulin resistance and beta cell activity in patients with Crohn's disease","volume":"12","author":"Bregenzer N","year":"2006","unstructured":"Bregenzer N, Hartmann A, Strauch U, Sch\u00f6lmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis. 2006, 12:53-6. 10.1097\/01.mib.0000195975.97673.f5","journal-title":"Inflamm Bowel Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281334d","article-title":"Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population","volume":"19","author":"Betteridge JD","year":"2013","unstructured":"Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013, 19:1421-7. 10.1097\/MIB.0b013e318281334d","journal-title":"Inflamm Bowel Dis"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819827692","article-title":"Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010","volume":"12","author":"Aniwan S","year":"2019","unstructured":"Aniwan S, Harmsen WS, Tremaine WJ, et al.. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol. 2019, 12:1756284819827692.","journal-title":"Therap Adv Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-83. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv138","article-title":"Renal involvement in inflammatory bowel diseases","volume":"10","author":"Corica D","year":"2016","unstructured":"Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2016, 10:226-35. 10.1093\/ecco-jcc\/jjv138","journal-title":"J Crohns Colitis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/642923","article-title":"Liver disorders in inflammatory bowel disease","volume":"2012","author":"Uko V","year":"2012","unstructured":"Uko V, Thangada S, Radhakrishnan K. Liver disorders in inflammatory bowel disease. Gastroenterol Res Pract. 2012, 2012:642923. 10.1155\/2012\/642923","journal-title":"Gastroenterol Res Pract"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.56343","article-title":"Pulmonary manifestations of inflammatory bowel disease","volume":"11","author":"Majewski S","year":"2015","unstructured":"Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci. 2015, 11:1179-88. 10.5114\/aoms.2015.56343","journal-title":"Arch Med Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000891","article-title":"Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland","volume":"29","author":"B\u00e4hler C","year":"2017","unstructured":"B\u00e4hler C, Schoepfer AM, Vavricka SR, Br\u00fcngger B, Reich O. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. Eur J Gastroenterol Hepatol. 2017, 29:916-25. 10.1097\/MEG.0000000000000891","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-020-0115-2","article-title":"Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study","volume":"4","author":"Hudesman DP","year":"2020","unstructured":"Hudesman DP, Chakravarty SD, Emond B, Ellis LA, Lefebvre P, Sadik K, Scher JU. Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study. BMC Rheumatol. 2020, 4:16. 10.1186\/s41927-020-0115-2","journal-title":"BMC Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113045-the-impact-of-inflammatory-bowel-disease-on-mortality-and-other-outcomes-of-hospitalized-patients-with-diabetic-ketoacidosis-an-observational-study-of-the-united-states-national-inpatient-sample","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:01Z","timestamp":1707507601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113045-the-impact-of-inflammatory-bowel-disease-on-mortality-and-other-outcomes-of-hospitalized-patients-with-diabetic-ketoacidosis-an-observational-study-of-the-united-states-national-inpatient-sample"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.28697","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}